Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BMEA |
---|---|---|
09:32 ET | 134574 | 11.6168 |
09:34 ET | 127091 | 11.28 |
09:36 ET | 107920 | 11.65 |
09:38 ET | 125389 | 11.5633 |
09:39 ET | 42649 | 11.6 |
09:41 ET | 82933 | 11.64 |
09:43 ET | 110890 | 11.31 |
09:45 ET | 104466 | 10.755 |
09:48 ET | 143865 | 10.6 |
09:50 ET | 67614 | 10.78 |
09:52 ET | 54328 | 10.8499 |
09:54 ET | 41749 | 10.65 |
09:56 ET | 34636 | 10.48 |
09:57 ET | 93362 | 10.12 |
09:59 ET | 47563 | 10.31 |
10:01 ET | 24330 | 10.585 |
10:03 ET | 31866 | 10.25 |
10:06 ET | 67409 | 10.2172 |
10:08 ET | 69483 | 9.9008 |
10:10 ET | 38877 | 9.975 |
10:12 ET | 62915 | 9.78 |
10:14 ET | 35210 | 9.95 |
10:15 ET | 14268 | 9.975 |
10:17 ET | 25747 | 9.985 |
10:19 ET | 17135 | 10.11 |
10:21 ET | 43394 | 10.19 |
10:24 ET | 49071 | 10 |
10:26 ET | 12530 | 10 |
10:28 ET | 30974 | 10.13 |
10:30 ET | 37342 | 9.99 |
10:32 ET | 29594 | 9.925 |
10:33 ET | 11309 | 9.935 |
10:35 ET | 11724 | 9.975 |
10:37 ET | 18027 | 9.9634 |
10:39 ET | 8214 | 9.9525 |
10:42 ET | 37276 | 9.75 |
10:44 ET | 34348 | 9.88 |
10:46 ET | 2633 | 9.915 |
10:48 ET | 6319 | 9.98 |
10:50 ET | 5206 | 9.9802 |
10:51 ET | 7892 | 9.99 |
10:53 ET | 24880 | 9.9304 |
10:55 ET | 10992 | 9.9 |
10:57 ET | 6876 | 9.8808 |
11:00 ET | 3727 | 9.98 |
11:02 ET | 19461 | 10.005 |
11:04 ET | 8104 | 9.985 |
11:06 ET | 7446 | 9.965 |
11:08 ET | 1524 | 9.995 |
11:09 ET | 1157 | 9.99 |
11:11 ET | 5530 | 9.975 |
11:13 ET | 6030 | 9.975 |
11:15 ET | 2067 | 10 |
11:18 ET | 7716 | 10 |
11:20 ET | 2153 | 9.935 |
11:22 ET | 18682 | 9.95 |
11:24 ET | 13357 | 9.91 |
11:26 ET | 16626 | 9.89 |
11:27 ET | 2001 | 9.91 |
11:29 ET | 2047 | 9.92 |
11:31 ET | 17086 | 9.8 |
11:33 ET | 7055 | 9.88 |
11:36 ET | 2044 | 9.83 |
11:38 ET | 23186 | 10 |
11:40 ET | 9234 | 9.95 |
11:42 ET | 2140 | 9.94 |
11:44 ET | 3103 | 9.975 |
11:45 ET | 21831 | 9.99 |
11:47 ET | 5842 | 9.9201 |
11:49 ET | 500 | 9.95 |
11:51 ET | 4645 | 9.95 |
11:54 ET | 200 | 9.9351 |
11:56 ET | 3345 | 9.955 |
11:58 ET | 2408 | 9.97 |
12:00 ET | 3125 | 9.9401 |
12:02 ET | 23980 | 9.88 |
12:03 ET | 300 | 9.925 |
12:05 ET | 337 | 9.9289 |
12:07 ET | 3310 | 9.9499 |
12:09 ET | 1795 | 9.94 |
12:12 ET | 4296 | 9.92 |
12:14 ET | 2422 | 9.9136 |
12:16 ET | 3052 | 9.89 |
12:18 ET | 2845 | 9.97 |
12:20 ET | 1482 | 9.9517 |
12:21 ET | 1476 | 9.9869 |
12:23 ET | 2843 | 9.9801 |
12:25 ET | 1934 | 9.98 |
12:27 ET | 6712 | 9.95 |
12:30 ET | 5457 | 10.005 |
12:32 ET | 3300 | 9.985 |
12:34 ET | 10273 | 9.98 |
12:36 ET | 23250 | 9.98 |
12:38 ET | 10507 | 9.94 |
12:39 ET | 10445 | 9.95 |
12:41 ET | 1100 | 9.935 |
12:43 ET | 500 | 9.96 |
12:45 ET | 400 | 9.965 |
12:48 ET | 1006 | 9.99 |
12:50 ET | 2208 | 9.96 |
12:54 ET | 625 | 9.98 |
12:56 ET | 3211 | 9.985 |
12:57 ET | 10162 | 9.96 |
12:59 ET | 2481 | 9.97 |
01:01 ET | 6979 | 9.93 |
01:03 ET | 2521 | 9.92 |
01:06 ET | 2000 | 9.96 |
01:08 ET | 3791 | 9.95 |
01:10 ET | 435 | 9.95 |
01:12 ET | 2477 | 9.97 |
01:14 ET | 501 | 9.96 |
01:15 ET | 3650 | 9.9799 |
01:17 ET | 6701 | 10 |
01:19 ET | 2514 | 9.98 |
01:21 ET | 2761 | 10 |
01:24 ET | 13882 | 9.96 |
01:26 ET | 5089 | 9.98 |
01:28 ET | 700 | 9.96 |
01:30 ET | 5508 | 9.99 |
01:32 ET | 3908 | 9.985 |
01:33 ET | 680 | 9.99 |
01:35 ET | 400 | 9.99 |
01:37 ET | 4683 | 9.91 |
01:39 ET | 8735 | 9.8631 |
01:42 ET | 3200 | 9.8715 |
01:44 ET | 4100 | 9.92 |
01:46 ET | 4278 | 9.9285 |
01:48 ET | 1974 | 9.96 |
01:50 ET | 16573 | 9.98 |
01:51 ET | 5723 | 10.005 |
01:53 ET | 130564 | 10.135 |
01:55 ET | 10283 | 10.145 |
01:57 ET | 16207 | 10.275 |
02:00 ET | 42407 | 10.215 |
02:02 ET | 15622 | 10.23 |
02:04 ET | 15267 | 10.21 |
02:06 ET | 25975 | 10.175 |
02:08 ET | 2828 | 10.18 |
02:09 ET | 2631 | 10.2 |
02:11 ET | 7071 | 10.17 |
02:13 ET | 2450 | 10.17 |
02:15 ET | 3951 | 10.205 |
02:18 ET | 4918 | 10.18 |
02:20 ET | 3728 | 10.06 |
02:22 ET | 2690 | 10.07 |
02:24 ET | 9177 | 10.1 |
02:26 ET | 4717 | 10.14 |
02:27 ET | 7447 | 10.045 |
02:29 ET | 8399 | 10.01 |
02:31 ET | 1043 | 10 |
02:33 ET | 3038 | 10.06 |
02:36 ET | 500 | 10.05 |
02:38 ET | 100 | 10.035 |
02:40 ET | 11567 | 10.01 |
02:42 ET | 184 | 10.025 |
02:44 ET | 1752 | 10.015 |
02:45 ET | 2400 | 10.0109 |
02:47 ET | 5291 | 10.0501 |
02:49 ET | 1180 | 10.09 |
02:51 ET | 1402 | 10.085 |
02:54 ET | 320 | 10.085 |
02:56 ET | 1074 | 10.065 |
02:58 ET | 1093 | 10.05 |
03:00 ET | 2339 | 10.055 |
03:02 ET | 400 | 10.01 |
03:03 ET | 1252 | 9.9869 |
03:05 ET | 306 | 9.98 |
03:07 ET | 1400 | 10 |
03:09 ET | 1000 | 10.005 |
03:12 ET | 2913 | 10.005 |
03:14 ET | 1571 | 10.01 |
03:16 ET | 88526 | 10.04 |
03:18 ET | 40344 | 9.935 |
03:20 ET | 6133 | 9.99 |
03:21 ET | 1045 | 9.985 |
03:23 ET | 1600 | 9.99 |
03:25 ET | 5669 | 9.96 |
03:27 ET | 4894 | 9.98 |
03:30 ET | 1708 | 9.98 |
03:32 ET | 14447 | 9.94 |
03:34 ET | 2059 | 9.955 |
03:36 ET | 11083 | 9.92 |
03:38 ET | 3760 | 9.94 |
03:39 ET | 1000 | 9.93 |
03:41 ET | 3742 | 9.96 |
03:43 ET | 2801 | 10 |
03:45 ET | 2142 | 9.98 |
03:48 ET | 3989 | 9.92 |
03:50 ET | 2442 | 9.915 |
03:52 ET | 20313 | 9.87 |
03:54 ET | 6340 | 9.9 |
03:56 ET | 15960 | 9.93 |
03:57 ET | 11554 | 9.91 |
03:59 ET | 127135 | 9.9 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Biomea Fusion Inc | 284.2M | -2.5x | --- |
Acrivon Therapeutics Inc | 276.0M | -2.6x | --- |
enGene Holdings Inc | 295.8M | -1.3x | --- |
Rezolute Inc | 269.8M | -3.7x | --- |
Tectonic Therapeutic Inc | 265.1M | -1.7x | --- |
ESSA Pharma Inc | 303.9M | -10.3x | --- |
Biomea Fusion, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of oral covalent small molecules to treat patients with metabolic diseases and genetically defined cancers. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein. The Company is utilizing its proprietary FUSION System to discover, design and develop a pipeline of covalent-binding small molecule medicines designed to maximize clinical benefit for patients. Its lead product candidate, BMF-219, is designed to be an oral, potent, and selective covalent inhibitor of menin, built from its FUSION System. It is developing BMF-219 for the treatment of menin regulated or dependent diseases, such as type 1 and type 2 diabetes as well as subtypes of liquid and solid tumors. Its second development candidate, BMF-500, a covalent inhibitor of activating mutations of the FMS-like tyrosine kinase 3 (FLT3).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $284.2M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 36.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.47 |
EPS | $-3.90 |
Book Value | $4.72 |
P/E Ratio | -2.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.